Skip to main content

Table 5 Association of cancer-specific survival with treatment modality

From: Frequency, prognosis and treatment modalities of newly diagnosed small bowel cancer with liver metastases

 

Model 1

Model 2

Model 3

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

Part I: univariate analysis

 Small bowel cancer

  None

Ref

     

  Surgery only

0.15 (0.12–0.19)

< 0.001

Ref

   

  Chemo only

1.04 (0.87–1.25)

0.681

7.87 (6.18–10.0)

< 0.001

Ref

 

  Surgery + chemo

0.37 (0.29–0.47)

< 0.001

2.55 (1.93–3.38)

< 0.001

0.32 (0.25–0.41)

< 0.001

 Adenocarcinoma

  None

Ref

     

  Surgery only

0.50 (0.33–0.76)

0.001

Ref

   

  Chemo only

0.35 (0.28–0.44)

< 0.001

0.70 (0.46–1.07)

0.097

Ref

 

  Surgery + chemo

0.24 (0.18–0.33)

< 0.001

0.47 (0.29–0.75)

0.002

0.66 (0.49–0.89)

0.006

 Neuroendocrine carcinoma (NEC)

  None

Ref

     

  Surgery only

0.25 (0.18–0.35)

< 0.001

Ref

   

  Chemo only

0.13 (0.82–1.96)

0.280

5.20 (3.35–8.07)

< 0.001

Ref

 

  Surgery +chemo

0.44 (0.28–0.68)

< 0.001

1.75 (1.13–2.73)

0.013

0.34 (0.20–0.58)

< 0.001

 Gastrointestinal stromal sarcoma (GISS)

  None

Ref

     

  Surgery only

0.51 (0.14–1.94)

0.324

Ref

   

  Chemo only

0.18 (0.05–0.68)

0.012

0.35 (0.09-1.40)

0.138

Ref

 

  Surgery + chemo

0.25 (0.09–0.73)

0.012

0.48 (0.15–1.51)

0.209

1.36 (0.43–4.28)

0.599

Part II: multivariate analysisa

 Small bowel cancer

  None

Ref

     

  Surgery only

0.31 (0.22–0.43)

< 0.001

Ref

   

  Chemo only

0.70 (0.57–0.86)

0.001

3.04 (2.09–4.42)

< 0.001

Ref

 

  Surgery + chemo

0.41 (0.30–0.57)

< 0.001

1.48 (1.07–2.04)

0.018

0.47 (0.32–0.67)

< 0.001

 Adenocarcinoma

  None

Ref

     

  Surgery only

0.69 (0.40–1.18)

0.173

Ref

   

  Chemo only

0.35 (0.27–0.44)

< 0.001

0.57 (0.31–1.02)

0.058

Ref

 

  Surgery + chemo

0.27 (0.18–0.42)

< 0.001

0.37 (0.22–0.65)

< 0.001

0.67 (0.42–1.06)

0.089

 Neuroendocrine carcinoma (NEC)

  None

Ref

     

  Surgery only

0.24 (0.14–0.43)

< 0.001

Ref

   

  Chemo only

1.13 (0.68–1.88)

0.633

2.81 (1.41–5.63)

0.003

Ref

 

  Surgery + chemo

0.39 (0.20–0.73)

0.004

1.48 (0.91–2.41)

0.112

0.52 (0.21–1.31)

0.164

 Gastrointestinal stromal sarcoma (GISS)

  None

Ref

     

  Surgery only

0.31 (0.02–4.71)

0.397

Ref

   

  Chemo only

0.08 (0.01–0.69)

0.022

0.34 (0.04–2.81)

0.314

Ref

 

  Surgery + chemo

0.10 (0.01–1.24)

0.073

0.40 (0.08–2.00)

0.262

1.26 (0.21–7.73)

0.804

  1. CI confidence interval, HR hazard ratio, Chemo chemotherapy
  2. aAdjusted variables included age, gender, marital status, primary site, histologic grade, T stage, tumor size, N stage, and number of extrahepatic metastatic sites.